Replies to post #330753 on Innovation Pharmaceuticals Inc (IPIX)

[dpm58]

Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
October 28 2020 - 07:30AM
PR Newswire (US)
Alert
Print
Share On Facebook
ENGLEWOOD, Colo., Oct. 28, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today the Company has begun recruiting and enrolling patients in a Phase I multi-center, randomized, controlled trial for a total of 40 patients that will assess the safety and efficacy of inhaled Ampion added to the standard of care ("SOC") for COVID-19 infected patients hospitalized for respiratory distress. Dosing of patients will begin at Penrose Hospital in Colorado Springs, Colorado and will expand enrollment to other hospitals in the near future.

Ampio Pharmaceuticals Logo. (PRNewsFoto/Ampio Pharmaceuticals, Inc.) (PRNewsfoto/Ampio Pharmaceuticals, Inc.)

AMPE is enrolling patients. IPIX should not be far behind

[TheDane]

It’s good news all around.

[Golfguru03]

A company out of Australia (Starpharma) is developing an inhaler and recently received 1 m in funding..also testing against other respiratory viruses...one targeted group would be Doctors, Nurses and other front line workers...also could be effective in conjunction with a vaccine...

[MinnieM]

Numerous Vaccine and Drug Trials for Covid-19 in the World: A Review

http://jamdsr.com/uploadfiles/11covidvaccinetrialsvol8issue5pp44-47.20200510020240.pdf

Is the following a mistake or could there be an ongoing trial we simply haven't been made aware of? My guess is it's a mistake. Your thoughts? I found it while searching for inhaler research.